Milestone Pharmaceuticals Inc.
corporate_fare Company Profile
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for MIST at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 8 rated 8 or above. Recent SEC coverage for MIST spans 8-K, 10-Q, S-3, 10-K.
Recent high-impact activity:
- Milestone Posts Wider-Than-Expected Q3 Revenue, Narrows Loss to 18 Cents a Share
- Milestone Q3: CFO and CMO Out, 30% Cost Cut, RTW PIK Extended to 2029
- Milestone Cuts 30% of Costs, Extends Cash Runway to Late 2028 as CFO and CMO Exit
- Milestone Posts $80.5M Nine-Month Loss, Cuts 20% of Staff to Extend Runway
- Milestone Receives Nasdaq Bid-Price Deficiency Notice, 180 Days to April 21, 2027
Financial Snapshot
Short Interest & Short Volume
24.83 days to coverFINRA reported short interest of 19,895,670 shares in MIST as of the October 30, 2026 settlement, a 0.9% increase from the prior period — about 24.8 days to cover at its recent average daily volume. On November 13, 2026, 56.9% of MIST volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for MIST, detected from its recent SEC filings · based on capital-structure filings through 2026-06-15.
Equity Incentive Plan Expanded · Significant Potential Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →